David A. Siegel Clearside Biomedical, Inc. Transaction History

Two Sigma Advisers, LP

$43.8 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.82 - $1.27 $30,504 - $47,244	-37,200 Reduced 37.16%	62,900 $54,000
Q2 2023 Aug 14, 2023	SELL	$0.97 - $1.48 $15,617 - $23,828	-16,100 Reduced 13.86%	100,100 $112,000
Q1 2023 May 15, 2023	SELL	$0.93 - $1.66 $48,174 - $85,988	-51,800 Reduced 30.83%	116,200 $120,000
Q4 2022 Feb 14, 2023	SELL	$1.0 - $1.5 $55,000 - $82,500	-55,000 Reduced 24.66%	168,000 $188,000
Q3 2022 Nov 14, 2022	SELL	$1.08 - $1.83 $150,012 - $254,187	-138,900 Reduced 38.38%	223,000 $252,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.49 $385,320 - $738,036	-296,400 Reduced 45.03%	361,900 $532,000
Q1 2022 May 16, 2022	SELL	$1.35 - $2.88 $299,160 - $638,208	-221,600 Reduced 25.18%	658,300 $1.51 Million
Q4 2021 Feb 14, 2022	SELL	$2.72 - $5.72 $357,680 - $752,180	-131,500 Reduced 13.0%	879,900 $2.42 Million
Q3 2021 Nov 15, 2021	BUY	$4.83 - $7.2 $103,362 - $154,080	21,400 Added 2.16%	1,011,400 $6.07 Million
Q2 2021 Aug 16, 2021	BUY	$2.32 - $5.38 $784,624 - $1.82 Million	338,200 Added 51.89%	990,000 $4.82 Million
Q1 2021 May 17, 2021	BUY	$2.24 - $4.25 $1.35 Million - $2.56 Million	602,000 Added 1208.84%	651,800 $1.61 Million
Q4 2020 Feb 16, 2021	SELL	$1.32 - $2.74 $70,356 - $146,042	-53,300 Reduced 51.7%	49,800 $136,000
Q3 2020 Nov 16, 2020	BUY	$1.45 - $2.0 $149,495 - $206,200	103,100 New	103,100 $159,000
Q2 2019 Aug 14, 2019	SELL	$0.97 - $1.42 $19,400 - $28,400	-20,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.1 - $1.74 $22,000 - $34,800	20,000 New	20,000 $28,000
Q2 2018 Aug 14, 2018	SELL	$8.91 - $14.54 $101,574 - $165,756	-11,400 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.57 - $14.28 $63,498 - $162,792	11,400 New	11,400 $122,000

Others Institutions Holding CLSD

# of Institutions

Shares Held

13.4M

Call Options Held

17.6K

Put Options Held

100

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account